Course: Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient
CME Credits: 1.00
Released: 2021-03-09
In a recent , a team of physicians described an immunosuppressed patient with severe coronavirus disease 2019 (COVID-19) who was contagious for more than 2 months. Infectious virus was present in the patient’s endotracheal aspirate (ETA) 72 days after his COVID-19 diagnosis and 2 days before he died from the massive lung infection. The findings from the 73-year-old man, who had recently undergone chimeric antigen receptor T-cell (CAR-T) therapy, suggest that patients with COVID-19 who are severely immunosuppressed may need isolation for longer than the currently 20 days.
Educational Objective
To identify the key insights or developments described in this article
View Full Course